Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kava as an anticraving agent: preliminary data.

G G Steiner1

  • 1ggsteiner@yahoo.com

Pacific Health Dialog
|August 16, 2002
PubMed
Summary
This summary is machine-generated.

Kava may reduce drug cravings. Preliminary studies suggest its active compounds, kavapyrones, may decrease desire for substances like alcohol and tobacco, potentially aiding addiction treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The correlation between cancer incidence and kava consumption.

Hawaii medical journal·2001
Same author

Changes of the marginal periodontium as a result of labial tooth movement in monkeys.

Journal of periodontology·1981
Same journal

Speech: Sugary drink free Pacific by 2030? NZ by 2025? Tariana Turia.

Pacific health dialog·2015
Same journal

Policy brief: Options to reduce sugar sweetened beverage (SSB) consumption in New Zealand.

Pacific health dialog·2015
Same journal

The story of FiZZ: an advocacy group to end the sale of sugar sweetened beverages in New Zealand.

Pacific health dialog·2015
Same journal

Kelston Beverages Pilot Study: Rationale, design and implementation of a community and school based intervention to reduce sugary drink consumption among children and youth.

Pacific health dialog·2015
Same journal

Carbonated beverage consumption in New Zealand adults.

Pacific health dialog·2015
Same journal

Carbonated beverages consumption among New Zealand youth and associations with BMI and waist circumference.

Pacific health dialog·2015
See all related articles

Area of Science:

  • Neuroscience
  • Pharmacology
  • Addiction Research

Background:

  • Drug and alcohol abuse poses significant financial and social costs in the U.S.
  • Understanding the neurological basis of craving is crucial for effective addiction treatment.
  • Kava's active compounds, kavapyrones, interact with brain sites linked to addiction and craving.

Purpose of the Study:

  • To investigate kava's potential to reduce craving for substances of abuse.
  • To explore the effects of kavapyrones on addiction and withdrawal symptoms.

Main Methods:

  • A craving survey and pilot study were conducted.
  • Examined cravings for alcohol, tobacco, cocaine, and heroin.
  • One investigation used a standardized amount of kavapyrones versus a placebo.

Related Experiment Videos

Main Results:

  • Participants reported a reduced desire for their drug of choice.
  • A standardized dose of kavapyrones showed a difference in alcohol abstinence rates between groups.
  • Preliminary findings suggest kava may reduce addiction-related craving.

Conclusions:

  • Kava shows potential as an adjunct therapy for addiction treatment.
  • Further large-scale, systematic investigations are warranted.
  • Kava may be particularly beneficial for Native Hawaiian and Pacific populations.